Westerveld A - Search Results

1

Molecular analysis of genetic changes in ependymomas.

Bijlsma EK, Voesten AM, Bijleveld EH, Troost D, Westerveld A, Mérel P, Thomas G, Hulsebos TJ. Bijlsma EK, et al. Among authors: westerveld a. Genes Chromosomes Cancer. 1995 Aug;13(4):272-7. doi: 10.1002/gcc.2870130407. Genes Chromosomes Cancer. 1995. PMID: 7547635

2

Malignant astrocytoma-derived region of common amplification in chromosomal band 17p12 is frequently amplified in high-grade osteosarcomas.

Hulsebos TJ, Bijleveld EH, Oskam NT, Westerveld A, Leenstra S, Hogendoorn PC, Bras J. Hulsebos TJ, et al. Among authors: westerveld a. Genes Chromosomes Cancer. 1997 Apr;18(4):279-85. Genes Chromosomes Cancer. 1997. PMID: 9087567

3

Fine mapping of a region of common deletion on chromosome arm 10p in human glioma.

Voesten AM, Bijleveld EH, Westerveld A, Hulsebos TJ. Voesten AM, et al. Among authors: westerveld a. Genes Chromosomes Cancer. 1997 Oct;20(2):167-72. Genes Chromosomes Cancer. 1997. PMID: 9331567

4

Evidence for an ependymoma tumour suppressor gene in chromosome region 22pter-22q11.2.

Hulsebos TJ, Oskam NT, Bijleveld EH, Westerveld A, Hermsen MA, van den Ouweland AM, Hamel BC, Tijssen CC. Hulsebos TJ, et al. Among authors: westerveld a. Br J Cancer. 1999 Dec;81(7):1150-4. doi: 10.1038/sj.bjc.6690822. Br J Cancer. 1999. PMID: 10584875 Free PMC article.

5

Molecular characterization of areas with low grade tumor or satellitosis in human malignant astrocytomas.

Leenstra S, Troost D, Westerveld A, Bosch DA, Hulsebos TJ. Leenstra S, et al. Among authors: westerveld a. Cancer Res. 1992 Mar 15;52(6):1568-72. Cancer Res. 1992. PMID: 1311634

6

Molecular characterization of chromosome 22 deletions in schwannomas.

Bijlsma EK, Brouwer-Mladin R, Bosch DA, Westerveld A, Hulsebos TJ. Bijlsma EK, et al. Among authors: westerveld a. Genes Chromosomes Cancer. 1992 Oct;5(3):201-5. doi: 10.1002/gcc.2870050305. Genes Chromosomes Cancer. 1992. PMID: 1384671

7

Direct assignment of the human beta B2 and beta B3 crystallin genes to 22q11.2----q12: markers for neurofibromatosis 2.

Hulsebos TJ, Bijlsma EK, Geurts van Kessel AH, Brakenhoff RH, Westerveld A. Hulsebos TJ, et al. Among authors: westerveld a. Cytogenet Cell Genet. 1991;56(3-4):171-5. doi: 10.1159/000133080. Cytogenet Cell Genet. 1991. PMID: 2055112

8

Regional fine mapping of the beta crystallin genes on chromosome 22 excludes these genes as physically linked markers for neurofibromatosis type 2.

Bijlsma EK, Delattre O, Juyn JA, Melot T, Westerveld A, Dumanski JP, Thomas G, Hulsebos TJ. Bijlsma EK, et al. Among authors: westerveld a. Genes Chromosomes Cancer. 1993 Oct;8(2):112-8. doi: 10.1002/gcc.2870080208. Genes Chromosomes Cancer. 1993. PMID: 7504514

9

Amplification of the anonymous marker D17S67 in malignant astrocytomas.

Bijlsma EK, Leenstra S, Westerveld A, Bosch DA, Hulsebos TJ. Bijlsma EK, et al. Among authors: westerveld a. Genes Chromosomes Cancer. 1994 Feb;9(2):148-52. doi: 10.1002/gcc.2870090213. Genes Chromosomes Cancer. 1994. PMID: 7513547

10

Analysis of mutations in the SCH gene in schwannomas.

Bijlsma EK, Merel P, Bosch DA, Westerveld A, Delattre O, Thomas G, Hulsebos TJ. Bijlsma EK, et al. Among authors: westerveld a. Genes Chromosomes Cancer. 1994 Sep;11(1):7-14. doi: 10.1002/gcc.2870110103. Genes Chromosomes Cancer. 1994. PMID: 7529050

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

165 results

Search Page